Clinical Presentation, Treatment and Vaccination in COVID-19
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 12446
Special Issue Editors
Interests: COVID-19; infectious diseases; viral hepatitis
Interests: infectious diseases; viral hepatitis; liver; COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nearly two years have passed since the World Health Organization announced the pandemic of COVID-19. At the beginning, only supportive care was available; however, the rapid spread of COVID-19 around the world sparked a need for an antiviral agent active against SARS-CoV-2. Initially, the search for an effective therapy focused on drug repurposing and new ways of using approved agents with proven activity against other viruses. New antiviral drugs were then discovered following clinical trials, and are now available. During these two years, the spectrum of anti-inflammatory and immunosuppressive drugs used in the cytokine storm stage has also broadened. Despite growing knowledge of SARS-CoV-2 and experience in treating COVID-19, vaccines that became available at the end of 2020 are hugely important in the fight against the pandemic. However, new therapeutic possibilities and available prophylaxis influence the disease and its future. The clinical presentation of COVID-19 and prognosis also change with the appearance of new variants of the virus.
In this Special Issue, we would like to invite you to submit a wide variety of papers, including original research, short communications, reviews, and viewpoints, which will broaden the understanding of the topic of clinical diagnosis, treatment, and vaccination against COVID-19.
Prof. Dr. Dorota Zarębska-Michaluk
Prof. Dr. Robert Flisiak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- COVID-19 (coronavirus disease 2019)
- clinical presentation of COVID-19
- treatment of COVID-19
- vaccination against COVID-19
- management of COVID-19
- variants of SARS-CoV-2
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.